Categories: News

IONIQ Sciences Announces Acquisition of Intellectual Property and Buyout of License

SALT LAKE CITY, UT / ACCESSWIRE / March 9, 2022 / ProLung, Inc. dba IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that it has acquired from OT Acceptance, LLC (“OT Acceptance”) certain intellectual property formerly licensed to the Company by OT Acceptance. With this acquisition, the Company now owns (rather than licenses) all of the intellectual property used by it with respect to early cancer detection.

Mr. Jared Bauer, IONIQ’s CEO, stated, “We are delighted to make a significant addition to our early cancer detection IP portfolio. Acquiring these patents that were originally licensed to IONIQ has the potential to save a substantial amount in future royalty payments and secures our rights to the underlying technology. Today we are yet again another step closer to modernizing early-stage cancer detection.”

Mr. William A. Fresh, President and CEO of OT Acceptance, shared, “My dream has always been to make a difference for those at-risk of cancer. I have steadfastly believed that developing this early cancer detection technology will alleviate the suffering from this horrible disease. I am confident that IONIQ can make my dream a reality.”

About IONIQ Sciences, Inc.

IONIQ Sciences, Inc. is developing an advanced multi-cancer screening technology for early detection that has the potential to expand the therapeutic window, dramatically improve survivability and reduce the cost of healthcare. IONIQ Sciences operates at the confluence of its Electrical Impedance Analytics (EIA) or bioimpedance technology and Artificial Intelligence (AI). IONIQ Science’s first product utilizing its proprietary analytic platform, the IONIQ ProLung Test™ for lung cancer, has been designated a Breakthrough Device by the U.S. FDA.

For further information about IONIQ Sciences, Inc., please contact:
Andy Robertson | 1-801-736-0729 | acr@IONIQsciences.com
IONIQ Sciences, Vice President of Business Development

IONIQ Sciences, Inc.
350 W. 800 N., Suite 214
Salt Lake City, Utah 84103
USA
www.IONIQsciences.com

Follow IONIQ Sciences, Inc. on Twitter, Facebook and LinkedIn: @IONIQSciences

SOURCE: IONIQ Sciences, Inc.

View source version on accesswire.com:
https://www.accesswire.com/692173/IONIQ-Sciences-Announces-Acquisition-of-Intellectual-Property-and-Buyout-of-License

Staff

Recent Posts

Registration open for 13th Annual Meeting of the Society of Hematologic Oncology

The Society of Hematologic Oncology (SOHO) has opened registration for its annual meeting; register before…

23 minutes ago

Universal Technical Institute, Inc. to Hold Fiscal First Quarter 2025 Conference Call on Wednesday, February 5, 2025, at 4:30 p.m. ET

PHOENIX, Jan. 15, 2025 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE: UTI) (the "Company"), a leading…

6 hours ago

CathVision to Showcase Innovations at AF Symposium, Present New Science

COPENHAGEN, Denmark, Jan. 15, 2025 /PRNewswire/ -- CathVision, a leader in advanced electrophysiology (EP) solutions, is…

6 hours ago

Gastro Girl Unveils ‘Ask Gastro Girl’: The AI-Powered App Redefining Access to Digestive Health Support

Built on Gastro Girl's trusted, evidence-based knowledge base and powered by cutting-edge AI, the app…

6 hours ago

OnPoint AR-AI Receives Award for Granted U.S. Patent Covering Augmented Reality (AR) Display for Spinal Rod Placement Related Applications

OnPoint Surgical, a medical technology company pioneering Augmented Reality (AR) guidance and artificial intelligence (AI)…

6 hours ago

Extinguishing Wildfires with Light at Meta Photonix

SAN FRANCISCO, Jan. 15, 2025 /PRNewswire/ -- MetaPhotonix Inc. (MPI), a Silicon Valley startup, is…

6 hours ago